Repare Therapeutics Inc. Income Tax Expense (Benefit) in USD from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Repare Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2019 to Q3 2025.
  • Repare Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $145K, a 70.1% decline year-over-year.
  • Repare Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $763K, a 53.2% decline year-over-year.
  • Repare Therapeutics Inc. annual Income Tax Expense (Benefit) for 2024 was $1.44M.
  • Repare Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was -$9.38M, a 162% decline from 2022.
  • Repare Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $15.1M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Repare Therapeutics Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $763K $145K -$340K -70.1% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $1.1M $248K -$78K -23.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $1.18M $370K -$259K -41.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $1.44M $0 -$190K -100% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 $1.63M $485K +$16.8M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$15.2M $326K -$2.78M -89.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 -$12.4M $629K -$2.99M -82.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 -$9.38M $190K -$14.8M -98.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 $5.46M -$16.3M -$16.4M -30283% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $21.8M $3.11M +$3.08M +9324% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $18.7M $3.62M +$3.58M +11200% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $15.1M $15M +$15.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$293K $54K +$762K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.06M $33K +$454K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$1.51M $32K +$169K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$1.68M -$412K +$1.14M +73.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$2.82M -$708K -$814K -768% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$2.01M -$421K -$491K -701% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$1.52M -$137K -$190K -358% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$1.33M -$1.55M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $106K +$77K +266% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $70K +$50K +250% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $53K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $29K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $20K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13

Repare Therapeutics Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.44M +$10.8M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 -$9.38M -$24.5M -162% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 $15.1M +$16.8M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$1.68M -$353K -26.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$1.33M -$1.52M -779% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $195K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.